- Home
- BXC vs AMRN Comparison
BXC vs AMRN Comparison
Compare BXC & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BXC | AMRN |
|---|---|---|
| Founded | 2004 | 1989 |
| Country | United States | Ireland |
| Employees | 1700 | N/A |
| Industry | Wholesale Distributors | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 410.5M | 342.8M |
| IPO Year | 2004 | 1998 |
Fundamental Metrics
Financial Performance| Metric | BXC | AMRN |
|---|---|---|
| Price | $54.50 | $14.89 |
| Analyst Decision | Buy | Strong Sell |
| Analyst Count | 2 | 1 |
| Target Price | ★ $71.50 | $12.00 |
| AVG Volume (30 Days) | ★ 127.0K | 83.3K |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.00 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $181,104,000.00 |
| Revenue This Year | $5.04 | N/A |
| Revenue Next Year | $5.09 | $1.26 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 39.22 |
| 52 Week Low | $44.78 | $12.96 |
| 52 Week High | $87.88 | $20.90 |
Technical Indicators
Market Signals| Indicator | BXC | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 47.82 | 41.75 |
| Support Level | $51.36 | $14.76 |
| Resistance Level | $61.55 | $15.09 |
| Average True Range (ATR) | 3.39 | 0.80 |
| MACD | -1.01 | -0.17 |
| Stochastic Oscillator | 34.62 | 9.43 |
Price Performance
Historical ComparisonAbout BXC Bluelinx Holdings Inc.
BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh, and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.